SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-21-003957
Filing Date
2021-08-17
Accepted
2021-08-17 16:46:12
Documents
2
Period of Report
2021-08-11

Document Format Files

Seq Description Document Type Size
1 form3-08172021_010829.html 3  
1 form3-08172021_010829.xml 3 1721
2 ex24-08172021_010830.htm EX-24 6407
  Complete submission text file 0001415889-21-003957.txt   9589
Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 52 SUNRISE PARK ROAD NEW HAMPTON NY 43017
Business Address
Coelho Mary Theresa (Reporting) CIK: 0001720772 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37853 | Film No.: 211183376